🇺🇸 FDA
Patent

US 7217719

Spiroazacyclic compounds as monoamine receptor modulators

granted A61PA61P1/14A61P25/00

Quick answer

US patent 7217719 (Spiroazacyclic compounds as monoamine receptor modulators) held by ACADIA Pharmaceuticals Inc. expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADIA Pharmaceuticals Inc.
Grant date
Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61P, A61P1/14, A61P25/00, A61P25/06, A61P25/14